Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

Bertrand Coiffier, Barbara Pro, H. Miles Prince, Francine Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Peter Borchmann, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan, Andrei Shustov, Jean Nichols, Susan Carroll, John Balser, Barbara Balser, Steven Horwitz

Research output: Contribution to journal › Article › peer-review

560 Scopus citations

Fingerprint

Dive into the research topics of 'Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences